magent

Deterministic published-formula arithmetic plus ICD-10-CM, RxNorm, and LOINC. Pay in USDC on Base via x402.

Inferenceofflineeip155:8453Exactvia cdp
Leibovich-2018RccKidneyPrognosisCalculator
Calls · 30d
1→ 0%
This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 8 snapshots so far.
$13.75
Verified settled volume
2,750 settlements proven x402 by their on-chain EIP-3009 marker.
$0.0050
Listed price
As published in the catalog. Always read the live 402 before paying.
1
Calls · 30d
Upstream's own call count for this endpoint, not ours.
1
Unique payers · 30d
Last called 2026-09-02 04:40Z
Upstream on-chain volume
Reported by the source catalog.
Paid to
0x836Be278f1739fB4308091cD1852F7971Bc19Ee2

The wallet the 402 directs payment to. Its whole payment record — every payer, every chain — is on the merchant page.

Asset 0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913

Provider

The payTo wallet does not resolve to a registered ERC-8004 agent. That is not a verdict on the service — most of the catalog is unregistered.

Live 402 challenge

Captured by the enrichment pass, not read just now. Prices can change — always read the 402 the endpoint answers with.

{
  "error": "PAYMENT-SIGNATURE header is required",
  "accepts": [
    {
      "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
      "extra": {
        "name": "USD Coin",
        "version": "2",
        "paymentFlow": "upfront",
        "resourceUrl": "https://api.magentlab.com/api/calc/leibovich_2018",
        "assetTransferMethod": "eip3009"
      },
      "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
      "amount": "5000",
      "scheme": "exact",
      "network": "eip155:8453",
      "maxTimeoutSeconds": 600
    },
    {
      "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
      "extra": {
        "name": "USD Coin",
        "version": "2",
        "withdrawDelay": 86400,
        "receiverAuthorizer": "0x3721824a31197dcDD2984cF43b92B6cc8A87c0Fb",
        "assetTransferMethod": "eip3009"
      },
      "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
      "amount": "5000",
      "scheme": "batch-settlement",
      "network": "eip155:8453",
      "maxTimeoutSeconds": 600
    }
  ],
  "resource": {
    "url": "https://api.magentlab.com/api/calc/leibovich_2018",
    "tags": [
      "leibovich-2018",
      "rcc",
      "kidney",
      "prognosis",
      "calculator"
    ],
    "mimeType": "application/json",
    "description": "Leibovich 2018 histology-specific RCC models after surgery. Required histology clear_cell, papillary, or chromophobe. ccRCC PFS points (2010 TNM): t1a/t1b/t2a 0, t2b 2, t3a-t3c 3, t4 4; nx/n0 0, n1 2; size ≥10 cm 1; grade 1-2 0, 3 1, 4 3; necrosis 2; max 12; risk low 0-2, intermediate 3-5, high ≥6. Papillary and chromophobe return the 2018 three PFS groups (score 0-2). Not SSIGN. Not Leibovich 2003. magent does not stage or read pathology. Not a diagnosis. Not a medical device.",
    "serviceName": "magent"
  },
  "extensions": {
    "bazaar": {
      "info": {
        "input": {
          "type": "http",
          "method": "GET",
          "queryParams": {
            "n_stage": "n0",
            "t_stage": "t1a",
            "necrosis": false,
            "histology": "clear_cell",
            "nuclear_grade": 2,
            "tumor_size_cm": 3
          }
        },
        "output": {
          "type": "json",
          "example": {
            "risk": "low",
            "score": 0,
            "formula": "leibovich_2018",
            "n_stage": "n0",
            "t_stage": "t1a",
            "citation": {
              "id": "leibovich-2018",
              "doi": "10.1016/j.eururo.2018.01.005",
              "pmid": "29398265",
              "title": "Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery",
              "source": "Eur Urol. 2018;73(5):772-780",
              "authors": "Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP"
            },
            "necrosis": false,
            "histology": "clear_cell",
            "max_score": 12,
            "components": [
              {
                "value": "t1a",
                "factor": "t_stage",
                "points": 0,
                "present": true
              },
              {
                "value": "n0",
                "factor": "n_stage",
                "points": 0,
                "present": true
              },
              {
                "value": 3,
                "factor": "tumor_size_cm",
                "points": 0,
                "present": false
              },
              {
                "value": 2,
                "factor": "nuclear_grade",
                "points": 0,
                "present": true
              },
              {
                "factor": "necrosis",
                "points": 0,
                "present": false
              }
            ],
            "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
            "nuclear_grade": 2,
            "tumor_size_cm": 3,
            "formula_expression": "ccRCC PFS (Leibovich 2018, 2010 TNM): t_stage (t1a/t1b/t2a 0, t2b 2, t3a/t3b/t3c 3, t4 4) + n_stage (nx/n0 0, n1 2) + tumor_size_cm >=10 1 + nuclear_grade (1-2 0, 3 1, 4 3) + necrosis 2; max 12; risk low 0-2, intermediate 3-5, high >=6. papillary PFS groups: low grade 1-2 and t1-t2; intermediate grade 3 and t1-t2; high grade 4 or t3a-t4 (fat or thrombus). chromophobe PFS groups: low t1-t2 and nx/n0; intermediate t3a-t4 and nx/n0 (fat); high n1. Not Frank 2002 SSIGN. Not Leibovich 2003. No chromophobe CSS model."
          }
        },
        "iconUrl": "https://api.magentlab.com/favicon.ico"
      },
      "schema": {
        "type": "object",
        "$schema": "https://json-schema.org/draft/2020-12/schema",
        "required": [
          "input"
        ],
        "properties": {
          "input": {
            "type": "object",
            "required": [
              "type",
              "method"
            ],
            "properties": {
              "type": {
                "type": "string",
                "const": "http"
              },
              "method": {
                "enum": [
                  "GET",
                  "HEAD",
                  "DELETE"
                ],
                "type": "string"
              },
              "headers": {
                "type": "object",
                "additionalProperties": {
                  "type": "string"
                }
              },
              "queryParams": {
                "type": "object",
                "required": [
                  "histology",
                  "t_stage",
                  "n_stage",
                  "tumor_size_cm",
                  "nuclear_grade",
                  "necrosis"
                ],
                "properties": {
                  "n_stage": {
                    "enum": [
                      "nx",
                      "n0",
                      "n1"
                    ],
                    "type": "string",
                    "description": "2010 pathologic N as assigned by the caller (Leibovich 2018). nx or n0 scores 0 on ccRCC; n1 scores 2. Not n2 (2002 N). magent does not stage nodes."
                  },
                  "t_stage": {
                    "enum": [
                      "t1a",
                      "t1b",
                      "t2a",
                      "t2b",
                      "t3a",
                      "t3b",
                      "t3c",
                      "t4"
                    ],
                    "type": "string",
                    "description": "2010 pathologic T as assigned by the caller (Leibovich 2018). t1a, t1b, t2a, t2b, t3a, t3b, t3c, or t4. Not 1997/2002 T without a/b substages. magent does not stage the tumor."
                  },
                  "necrosis": {
                    "type": "boolean",
                    "description": "Histologic tumor necrosis as assigned by the caller (Leibovich 2018). true scores 2 on ccRCC. magent does not read slides."
                  },
                  "histology": {
                    "enum": [
                      "clear_cell",
                      "papillary",
                      "chromophobe"
                    ],
                    "type": "string",
                    "description": "Surgical histology as assigned by the caller (Leibovich 2018). clear_cell, papillary, or chromophobe. Not collecting-duct or unclassified. magent does not read slides."
                  },
                  "nuclear_grade": {
                    "type": "integer",
                    "description": "Nuclear grade 1-4 as assigned by the caller (Leibovich 2018). On ccRCC, 1-2 score 0; 3 scores 1; 4 scores 3. Integer 1-4 only; reject 0, 5, 1.5, and roman I. magent does not read slides."
                  },
                  "tumor_size_cm": {
                    "type": "number",
                    "description": "Maximum tumor size in cm as assigned by the caller (Leibovich 2018). Unrounded; 10.0 cm or greater scores 1 on ccRCC. Magent clamp 0.1-30, not a published range. magent does not measure the tumor."
                  }
                }
              }
            },
            "additionalProperties": false
          },
          "output": {
            "type": "object",
            "required": [
              "type"
            ],
            "properties": {
              "type": {
                "type": "string"
              },
              "example": {
                "type": "object"
              }
            }
          }
        }
      }
    }
  },
  "x402Version": 2
}

Accepts

The payment requirements as published to the catalog. Read the live 402 before paying — a price here is a claim, not a quote.

0.005USDC≈ $0.005 USD
on Base · exact scheme

Pay 0.005 USDC on Base to 0x836B…19Ee2. The signed payment is good for 10 minutes.

USD Coin contract
0x8335…02913
Payment window
10 minutes
As published
5000 smallest units
The catalog’s raw entry
[
  {
    "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
    "extra": {
      "name": "USD Coin",
      "version": "2",
      "paymentFlow": "upfront",
      "resourceUrl": "https://api.magentlab.com/api/calc/leibovich_2018",
      "assetTransferMethod": "eip3009"
    },
    "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
    "amount": "5000",
    "scheme": "exact",
    "network": "eip155:8453",
    "maxTimeoutSeconds": 600
  }
]

Extensions

{
  "bazaar": {
    "info": {
      "input": {
        "body": {
          "items": [
            {
              "n_stage": "n0",
              "t_stage": "t1a",
              "necrosis": false,
              "histology": "clear_cell",
              "nuclear_grade": 2,
              "tumor_size_cm": 3
            },
            {
              "n_stage": "n0",
              "t_stage": "t1a",
              "necrosis": false,
              "histology": "clear_cell",
              "nuclear_grade": 2,
              "tumor_size_cm": 3
            }
          ]
        },
        "type": "http",
        "method": "POST"
      },
      "output": {
        "type": "json",
        "example": {
          "path": "/api/calc/leibovich_2018",
          "count": 2,
          "items": [
            {
              "risk": "low",
              "score": 0,
              "formula": "leibovich_2018",
              "n_stage": "n0",
              "t_stage": "t1a",
              "citation": {
                "id": "leibovich-2018",
                "doi": "10.1016/j.eururo.2018.01.005",
                "pmid": "29398265",
                "title": "Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery",
                "source": "Eur Urol. 2018;73(5):772-780",
                "authors": "Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP"
              },
              "necrosis": false,
              "histology": "clear_cell",
              "max_score": 12,
              "components": [
                {
                  "value": "t1a",
                  "factor": "t_stage",
                  "points": 0,
                  "present": true
                },
                {
                  "value": "n0",
                  "factor": "n_stage",
                  "points": 0,
                  "present": true
                },
                {
                  "value": 3,
                  "factor": "tumor_size_cm",
                  "points": 0,
                  "present": false
                },
                {
                  "value": 2,
                  "factor": "nuclear_grade",
                  "points": 0,
                  "present": true
                },
                {
                  "factor": "necrosis",
                  "points": 0,
                  "present": false
                }
              ],
              "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
              "nuclear_grade": 2,
              "tumor_size_cm": 3,
              "formula_expression": "ccRCC PFS (Leibovich 2018, 2010 TNM): t_stage (t1a/t1b/t2a 0, t2b 2, t3a/t3b/t3c 3, t4 4) + n_stage (nx/n0 0, n1 2) + tumor_size_cm >=10 1 + nuclear_grade (1-2 0, 3 1, 4 3) + necrosis 2; max 12; risk low 0-2, intermediate 3-5, high >=6. papillary PFS groups: low grade 1-2 and t1-t2; intermediate grade 3 and t1-t2; high grade 4 or t3a-t4 (fat or thrombus). chromophobe PFS groups: low t1-t2 and nx/n0; intermediate t3a-t4 and nx/n0 (fat); high n1. Not Frank 2002 SSIGN. Not Leibovich 2003. No chromophobe CSS model."
            },
            {
              "risk": "low",
              "score": 0,
              "formula": "leibovich_2018",
              "n_stage": "n0",
              "t_stage": "t1a",
              "citation": {
                "id": "leibovich-2018",
                "doi": "10.1016/j.eururo.2018.01.005",
                "pmid": "29398265",
                "title": "Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery",
                "source": "Eur Urol. 2018;73(5):772-780",
                "authors": "Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP"
              },
              "necrosis": false,
              "histology": "clear_cell",
              "max_score": 12,
              "components": [
                {
                  "value": "t1a",
                  "factor": "t_stage",
                  "points": 0,
                  "present": true
                },
                {
                  "value": "n0",
                  "factor": "n_stage",
                  "points": 0,
                  "present": true
                },
                {
                  "value": 3,
                  "factor": "tumor_size_cm",
                  "points": 0,
                  "present": false
                },
                {
                  "value": 2,
                  "factor": "nuclear_grade",
                  "points": 0,
                  "present": true
                },
                {
                  "factor": "necrosis",
                  "points": 0,
                  "present": false
                }
              ],
              "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
              "nuclear_grade": 2,
              "tumor_size_cm": 3,
              "formula_expression": "ccRCC PFS (Leibovich 2018, 2010 TNM): t_stage (t1a/t1b/t2a 0, t2b 2, t3a/t3b/t3c 3, t4 4) + n_stage (nx/n0 0, n1 2) + tumor_size_cm >=10 1 + nuclear_grade (1-2 0, 3 1, 4 3) + necrosis 2; max 12; risk low 0-2, intermediate 3-5, high >=6. papillary PFS groups: low grade 1-2 and t1-t2; intermediate grade 3 and t1-t2; high grade 4 or t3a-t4 (fat or thrombus). chromophobe PFS groups: low t1-t2 and nx/n0; intermediate t3a-t4 and nx/n0 (fat); high n1. Not Frank 2002 SSIGN. Not Leibovich 2003. No chromophobe CSS model."
            }
          ]
        }
      },
      "iconUrl": "https://api.magentlab.com/favicon.ico"
    },
    "schema": {
      "type": "object",
      "$schema": "https://json-schema.org/draft/2020-12/schema",
      "required": [
        "input"
      ],
      "properties": {
        "input": {
          "type": "object",
          "required": [
            "type",
            "method"
          ],
          "properties": {
            "body": {
              "type": "object",
              "required": [
                "items"
              ],
              "properties": {
                "items": {
                  "type": "array",
                  "items": {
                    "type": "object",
                    "required": [
                      "histology",
                      "t_stage",
                      "n_stage",
                      "tumor_size_cm",
                      "nuclear_grade",
                      "necrosis"
                    ],
                    "properties": {
                      "n_stage": {
                        "enum": [
                          "nx",
                          "n0",
                          "n1"
                        ],
                        "type": "string",
                        "description": "2010 pathologic N as assigned by the caller (Leibovich 2018). nx or n0 scores 0 on ccRCC; n1 scores 2. Not n2 (2002 N). magent does not stage nodes."
                      },
                      "t_stage": {
                        "enum": [
                          "t1a",
                          "t1b",
                          "t2a",
                          "t2b",
                          "t3a",
                          "t3b",
                          "t3c",
                          "t4"
                        ],
                        "type": "string",
                        "description": "2010 pathologic T as assigned by the caller (Leibovich 2018). t1a, t1b, t2a, t2b, t3a, t3b, t3c, or t4. Not 1997/2002 T without a/b substages. magent does not stage the tumor."
                      },
                      "necrosis": {
                        "type": "boolean",
                        "description": "Histologic tumor necrosis as assigned by the caller (Leibovich 2018). true scores 2 on ccRCC. magent does not read slides."
                      },
                      "histology": {
                        "enum": [
                          "clear_cell",
                          "papillary",
                          "chromophobe"
                        ],
                        "type": "string",
                        "description": "Surgical histology as assigned by the caller (Leibovich 2018). clear_cell, papillary, or chromophobe. Not collecting-duct or unclassified. magent does not read slides."
                      },
                      "nuclear_grade": {
                        "type": "integer",
                        "description": "Nuclear grade 1-4 as assigned by the caller (Leibovich 2018). On ccRCC, 1-2 score 0; 3 scores 1; 4 scores 3. Integer 1-4 only; reject 0, 5, 1.5, and roman I. magent does not read slides."
                      },
                      "tumor_size_cm": {
                        "type": "number",
                        "description": "Maximum tumor size in cm as assigned by the caller (Leibovich 2018). Unrounded; 10.0 cm or greater scores 1 on ccRCC. Magent clamp 0.1-30, not a published range. magent does not measure the tumor."
                      }
                    }
                  },
                  "maxItems": 25,
                  "minItems": 1
                }
              },
              "additionalProperties": false
            },
            "type": {
              "type": "string",
              "const": "http"
            },
            "method": {
              "type": "string",
              "const": "POST"
            },
            "headers": {
              "type": "object",
              "additionalProperties": {
                "type": "string"
              }
            }
          },
          "additionalProperties": false
        },
        "output": {
          "type": "object",
          "required": [
            "type"
          ],
          "properties": {
            "type": {
              "type": "string"
            },
            "example": {
              "type": "object"
            }
          }
        }
      }
    }
  }
}

Provenance

Seen in the source catalog
2026-09-02 04:40Z
Last indexed by Roundhouse
2026-09-07 06:20Z
Last enriched (probe, favicon, geo)
2026-09-10 20:15Z
x402 version
2
Max timeout
600s
Liveness probe
HTTP 0
Report

Hand this page to an agent

Copy the prompt and paste it into Claude, an MCP client or your own agent — it will vet this service and call it over the free read API. No key, no account.

GET api.roundhouseai.io/v0/endpoints

This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 8 snapshots so far. Verified volume counts only settlements with an on-chain EIP-3009 marker.

Open skill.md
Show the prompt
Using Roundhouse, look up the x402 service magent and tell me whether it is
worth paying: what a call costs, whether the endpoint answered when last probed, and what
its payment record actually shows.

curl -s 'https://api.roundhouseai.io/v0/endpoints?q=magent'
curl -s 'https://api.roundhouseai.io/v0/merchants/<the payTo wallet returned above>'

Then call it: read the price from the live 402 at https://api.magentlab.com/api/calc/leibovich_2018, never from
a cached figure, and pay with an x402 client.

The /v0 API needs an API key (`authorization: Bearer rh_live_…`) on everything except
/v0/unified* and /v0/endpoints. Mint a personal key for $0.01 at GET https://api.roundhouseai.io/v0/test/x402,
or use an organization key from https://roundhouseai.io/dashboard/team.

If you do not have Roundhouse tools or skills installed, read
https://roundhouseai.io/skill.md first — it is the whole procedure.